Kayne Anderson Midstream/Energy Fund Provides Unaudited

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
73
Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at March 31, 2019

HOUSTON, April 01, 2019 (GLOBE NEWSWIRE) -- Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of March 31, 2019. 

As of March 31, 2019, the Fund’s net assets were $671 million and its net asset value per share was $13.73.  As of March 31, 2019, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 471% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 343%.

         
Kayne Anderson Midstream/Energy Fund, Inc.
Statement of Assets and Liabilities
March 31, 2019
(Unaudited)
    (in millions)   Per Share
Investments   $   912.4     $   18.67  
Cash and cash equivalents       35.7         0.73  
Deposits       0.3       0.01  
Accrued income       1.1         0.02  
Receivable for securities sold       0.4       0.01  
Other assets       0.5       0.01  
Total assets       950.4         19.45  
         
Notes       200.9         4.11  
Unamortized notes issuance costs       (0.6 )       (0.01 )
Preferred stock       75.0         1.53  
Unamortized preferred stock issuance costs       (0.6 )       (0.01 )
Total leverage       274.7         5.62  
         
Payable for securities purchased       2.0         0.04  
Other liabilities       2.7         0.06  
Total liabilities       4.7         0.10  
         
Net assets   $   671.0     $   13.73  
         
The Fund had 48,878,499 common shares outstanding as of March 31, 2019.
         

As of March 31, 2019, equity and debt investments were 98% and 2%, respectively, of the Fund’s long-term investments of $912 million.  Long-term investments were comprised of Midstream Company (69%), Midstream MLP (26%), Other Energy (3%), and Debt (2%).

The Fund’s ten largest holdings by issuer at March 31, 2019 were:

  Units / Shares (in thousands)   Amount (in millions)   Percent of Long-Term Investments
1. ONEOK, Inc. (Midstream Company) 1,262   $88.1   9.7%
2. The Williams Companies, Inc. (Midstream Company) 2,696   77.4   8.5%
3. Plains GP Holdings, L.P. (Midstream Company) 2,895   72.1   7.9%
4. Enbridge Inc. (Midstream Company) 1,555   56.4   6.2%
5. Kinder Morgan, Inc. (Midstream Company) 2,419   48.4   5.3%
6. Enterprise Products Partners L.P. (Midstream MLP) 1,532   44.6   4.9%
7. Targa Resources Corp. (Midstream Company) 1,053   43.8   4.8%
8. Pembina Pipeline Corporation (Midstream Company) 1,172   43.1   4.7%
9. Energy Transfer LP (Midstream MLP) 2,588   39.8   4.4%
10. TransCanada Corporation (Midstream Company) 794   35.7   3.9%
           

Portfolio holdings are subject to change without notice. The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security. You can obtain a complete listing of holdings by viewing the Fund’s most recent quarterly or annual report.

Kayne Anderson Midstream/Energy Fund, Inc. is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, whose common stock is traded on the NYSE. The Fund’s investment objective is to provide a high level of total return with an emphasis on making cash distributions to its stockholders by investing at least 80% of its total assets in securities of companies in the Midstream/Energy Sector, consisting of: (a) Midstream Master Limited Partnerships (“MLPs”), (b) Midstream Companies, (c) Other MLPs and (d) Other Energy Companies. The Fund anticipates that the majority of its investments will consist of investments in Midstream MLPs and Midstream Companies. See Glossary of Key Terms in the Fund’s quarterly reports for a description of these investment categories and for the meaning of capitalized terms.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of any securities in any jurisdiction in which such offer or sale is not permitted. Past performance is not a guarantee of future results. Current performance may be lower or higher than that shown based on market fluctuations from the end of the reported period.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statements. These risks include, but are not limited to, changes in economic and political conditions; regulatory and legal changes; MLP industry risk; leverage risk; valuation risk; interest rate risk; tax risk; and other risks discussed in the Fund’s filings with the SEC, available at www.sec.gov. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objective will be attained.

Contact:

KA Fund Advisors, LLC 877-657-3863 http://www.kaynefunds.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 0

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 3

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Auto Loan Preapproval for Smart Buying

Updated Category News Views 8

A Fresh Perspective on Auto Loan Preapproval Diving into the maze of auto financing, sometimes you gotta stop and smell the coffee—that's where this HelloNation piece comes in, serving a dose of clarity for potential car buyers. Brad Bailey, the top dog at Red River Credit Union, steps into the fray to break it down. Gaining Financial Insight Ahead of the Game Think of...

Continue Reading
ArcelorMittal's Vision for Decarbonization in Europe Highlights

Updated Category News Views 147

ArcelorMittal's Commitment to Decarbonization ArcelorMittal is on a transformative journey to reshape its decarbonization strategy in Europe. The company has laid out a roadmap that prioritizes the replacement of traditional blast furnaces with lower carbon emissions facilities, specifically hydrogen-ready DRI-EAF systems. This endeavor marks a pivotal step forward in...

Continue Reading
Will International Stocks Outperform U.S. Markets This Year?

Updated Category News Views 193

Can International Stocks Surpass U.S. Performance? According to recent insights from a Vanguard economist, the landscape for stock investments is shifting, suggesting that international markets might finally outpace U.S. stocks. After facing challenges early in the year, U.S. stocks have rebounded impressively. The S&P 500 index has increased by approximately 16%...

Continue Reading
MellingMedical Secures Federal Supply Schedule for Pharmaceuticals

Updated Category News Views 216

MellingMedical Receives Federal Supply Schedule Contract MellingMedical proudly announces its successful acquisition of a federal contract specifically designed for essential pharmaceuticals. This new agreement plays a pivotal role in ensuring America's veterans have timely access to critical medications and health products. Understanding the Federal Supply Schedule The...

Continue Reading
GBM Gains Edge with Dr. Paik's Strategic Appointment

Updated Category News Views 9

A Heavyweight Joins the Global Battery Materials Camp This isn't your run-of-the-mill executive shuffle, folks. Global Battery Materials Corp. (GBM) has just brought in a marksman in the battery world—Dr. Yi Hyon Paik. The guy doesn't just dabble; he's chalked up over 30 years in the trenches of battery technology, electronic materials, and the big leagues of energy...

Continue Reading